US Patent Issued to FluGen on Sept. 8 for "Vaccine using M2/BM2-deficient influenza vectors" (Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,160, issued on Sept. 8, was assigned to FluGen Inc. (Madison, Wis.).

"Vaccine using M2/BM2-deficient influenza vectors" was invented by Michael J. Moser (Madison, Wis.), David J. Marshall (Madison, Wis.), Liam I. Marshall (Madison, Wis.), Yasuko Hatta (Madison, Wis.) and Pamuk Bilsel (Madison, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a recombinant virus comprising an influenza viral backbone, wherein the influenza viral backbone comprises PB1, PB2, PA, NP, M, NS, HA, and NA gene segments, wherein at least one of the PB1, PB2, PA, NP, M, NS, HA, and NA gene segments comprises at least one nucleotide sequence that enc...